• Lindsay A Tetreault, Joseph R Dettori, Jefferson R Wilson, Anoushka Singh, Aria Nouri, Michael G Fehlings, Erika D Brodt, and W Bradley Jacobs.
• *University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada † Spectrum Research, Inc., Tacoma, WA ‡Divisions of Neurosurgery and Orthopedic Surgery, Spinal Program, University of Toronto, Toronto, Ontario, Canada §Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada ¶Institute of Medical Science, University of Toronto, Division of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada ‖Division of Neurosurgery and Spinal Program Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; and **Calgary Spine Program, Foothills Medical Centre, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
• Spine. 2013 Oct 15; 38 (22 Suppl 1): S89-110.

Study DesignSystematic review.ObjectiveTo determine whether there are magnetic resonance imaging (MRI) characteristics in patients with cervical spondylotic myelopathy that affect treatment decisions or predict postsurgical outcomes or adverse events.Summary Of Background DataAlthough the role of MRI in confirming the clinical diagnosis of cervical spondylotic myelopathy and directing surgical management is well established, its potential value as a prognostic tool is largely unknown.MethodsA systematic search was conducted using PubMed and the Cochrane Collaboration Library for articles published between January 1, 1956, and November 20, 2012. The overall body of evidence with respect to each clinical question was determined on the basis of precepts outlined by the Grading of Recommendation Assessment, Development and Evaluation Working Group and recommendations made by the Agency for Healthcare Research and Quality.ResultsThe initial search yielded 268 citations. Twenty publications met all inclusion criteria and were included in the review. Three of these assessed MRI predictors of clinical deterioration in the case of conservative treatment and 17 evaluated MRI anatomic or cord characteristics that could predict surgical outcome or adverse events. There is low evidence suggesting that a high signal intensity (SI) grade on T2WI is not associated with patient deterioration during conservative treatment. High SI grade on T2WI, along with compression ratio and canal diameter, was not an important predictor of outcome. There is low evidence identifying number of high SI segments on T2WI, low SI segments on T1WI, combined T1/T2 SI, and SI ratio as important negative predictors of surgical outcome.ConclusionOn the basis of this review and on low-quality evidence, we have identified 3 important negative predictors of surgical outcome: number of high SI segments on T2WI, combined T1/T2 signal change, and SI ratio.EVIDENCE-BASED CLINICAL RECOMMENDATIONS:Recommendation 1We suggest that when clinically feasible, surgeons rely on MRI to confirm the diagnosis of CSM and rely on clinical history and examination to determine progression and severity of disease.Overall Strength Of EvidenceLow.Strength Of RecommendationWeak.Recommendation 2T2 signal may be a useful prognostic indicator when used in combination with low SI change on T1WI, or as a ratio comparing compressed with noncompressed segments, or as a ratio of T2 compared with T1WI. We suggest that if surgeons use MRI signal intensity to estimate the risk of a poor outcome after surgery, they use high SI change on T2WI in combination with other signal intensity parameters, and not in isolation.Overall Strength Of EvidenceLow. StrENGTH OF RECOMMENDATION: Weak.

17 keywords...

hide…